Hippo signalling is a cell signalling pathway that controls organ size. Activation of Hippo results in a series of phosphorylation events that culminate in the phosphorylation and cytoplasmic ...

California-based Vivace Therapeutics has announced the closing of a $35 million Series D financing. The proceeds will support ...

The expansion of the Salvador (SAV)–Warts (WTS)–Hippo (HPO) pathway continues with three recent papers that extend the list of upstream regulators and identify links to Wnt signalling.

The HIPPO pathway can modulate EMT by regulating YAP/TAZ activity. The interplay between these pathways influences EMT dynamics, impacting liver regeneration and disease progression.

Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class cancer therapies targeting the Hippo pathway, today announced the closing of a $35 million ...